Lantern Pharma Inc. Common Stock

LTRN XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

48M

Short interest (May 15)

16.8%

Net Short (Jun 03 ): 0.0%

Borrow Fee

9.80%

↓ 38.4%

Available Shares

500K

↑ 16.3%

Price Chart

Company Overview

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001763950

Asset Type: CS

Market Data

Market Cap: $47,718,181

Employees: 16

Status: Active

Short Interest

Current Borrow Fee 9.80%

Range: 9.80% - 10.16%

Available Shares 500K

Range: 500K - 600K

Recent Changes

Fee Change: ↓ 5.4%

Available Change: ↑ 5.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime